title: Efficacy and ligand bias at the μ-opioid receptor.
abstract: In order to describe drug action at a GPCR, a full understanding of the pharmacological terms affinity, efficacy and potency is necessary. This is true whether comparing the ability of different agonists to produce a measurable response in a cell or tissue, or determining the relative ability of an agonist to activate a single receptor subtype and produce multiple responses. There is a great deal of interest in the μ-opioid receptor (MOP receptor) and the ligands that act at this GPCR not only because of the clinically important analgesic effects produced by MOP agonists but also because of their liability to induce adverse effects such as respiratory depression and dependence. Our understanding of the mechanisms underlying these effects, as well as the ability to develop new, more effective MOP receptor drugs, depends upon the accurate determination of the efficacy with which these ligands induce coupling of MOP receptors to downstream signalling events. In this review, which is written with the minimum of mathematical content, the basic meaning of terms including efficacy, intrinsic activity and intrinsic efficacy is discussed, along with their relevance to the field of MOP receptor pharmacology, and in particular in relation to biased agonism at this important GPCR.
authors: School of Physiology and Pharmacology, University of Bristol, Bristol, UK. E.Kelly@bristol.ac.uk
authors: E
authors: E
authors: Kelly
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000494:pharmacology*; D006801:Humans; D009020:Morphine / Q000494:pharmacology*; D017450:Receptors, Opioid, mu / Q000819:agonists* / Q000378:metabolism
chemical_list: D000701:Analgesics, Opioid; D017450:Receptors, Opioid, mu; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D009020:Morphine
keywords: GPCR; efficacy; intrinsic efficacy; ligand bias; μ-opioid receptor
references: Trends Mol Med. 2011 Mar;17(3):126-39
references: 21183406
references: Eur J Neurosci. 2009 Jan;29(2):307-18
references: 19200236
references: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7157-62
references: 9618555
references: Neuron. 1999 Aug;23(4):737-46
references: 10482240
references: J Biol Chem. 2011 Sep 9;286(36):31731-41
references: 21757712
references: J Pharmacol Exp Ther. 2000 Mar;292(3):1127-34
references: 10688632
references: Drug Alcohol Depend. 2012 Mar 1;121(3):181-8
references: 22119134
references: Eur J Pharmacol. 1995 Dec 12;287(2):135-43
references: 8749027
references: Lancet. 1999 Jun 26;353(9171):2229-32
references: 10393001
references: Br J Pharmacol. 2010 Nov;161(6):1276-90
references: 20977467
references: Br J Pharmacol. 2013 Feb;168(3):554-75
references: 22994528
references: Br J Pharmacol. 2008 Apr;153(7):1353-63
references: 18223670
references: Br J Pharmacol. 1995 Jul;115(6):925-32
references: 7582522
references: Br J Pharmacol. 2008 Mar;153 Suppl 1:S379-88
references: 18059321
references: J Biomol Screen. 2011 Aug;16(7):706-16
references: 21550962
references: Nat Rev Drug Discov. 2013 Mar;12(3):205-16
references: 23411724
references: J Biol Chem. 2003 May 23;278(21):18776-84
references: 12642578
references: ACS Chem Neurosci. 2012 Mar 21;3(3):193-203
references: 22860188
references: J Pharmacol Exp Ther. 1998 May;285(2):496-505
references: 9580589
references: Drug Discov Today Technol. 2010 Spring;7(1):e1-e94
references: 24103682
references: Nat Chem Biol. 2011 Aug 21;7(10):692-700
references: 21857662
references: Methods Mol Biol. 2012;897:109-38
references: 22674163
references: J Pharmacol Exp Ther. 1996 Sep;278(3):1121-7
references: 8819494
references: Mol Pharmacol. 2007 Feb;71(2):549-57
references: 17090705
references: Science. 1999 Dec 24;286(5449):2495-8
references: 10617462
references: Br J Pharmacol. 1998 Nov;125(5):924-47
references: 9846630
references: Pharmacol Rev. 2011 Dec;63(4):1001-19
references: 21873412
references: Br J Pharmacol Chemother. 1956 Dec;11(4):379-93
references: 13383117
references: Life Sci. 1982 Oct 18-25;31(16-17):1687-90
references: 6296572
references: Br J Pharmacol. 2011 Nov;164 Suppl 1:S1-324
references: 22040146
references: Mol Pharmacol. 1997 Jan;51(1):87-96
references: 9016350
references: Life Sci. 1983;33 Suppl 1:327-30
references: 6319887
references: Toxicol Rev. 2006;25(2):79-85
references: 16958555
references: J Neurosci. 2011 Mar 23;31(12):4434-43
references: 21430144
references: Methods Mol Biol. 2012;897:181-203
references: 22674166
references: Neuroscience. 1999 Mar;90(3):1051-9
references: 10218804
references: J Neurosci. 2005 Aug 24;25(34):7847-57
references: 16120787
references: Mol Pharmacol. 2011 Feb;79(2):298-307
references: 20978120
references: Br J Anaesth. 2005 Jun;94(6):825-34
references: 15833777
references: Peptides. 2000 Dec;21(12):1871-4
references: 11150648
references: Peptides. 2006 Jun;27(6):1507-13
references: 16413634
references: Mol Pharmacol. 2012 Dec;82(6):1174-82
references: 22973061
references: Pharm Res. 2000 Jun;17(6):653-9
references: 10955836
references: J Pharmacol Exp Ther. 1998 Mar;284(3):1095-103
references: 9495871
references: Dev Cell. 2012 Sep 11;23(3):519-32
references: 22940114
references: J Biol Chem. 2010 Apr 23;285(17):12522-35
references: 20189994
references: EMBO J. 2004 Aug 18;23(16):3282-9
references: 15272312
references: J Neurosci. 2003 May 15;23(10):4324-32
references: 12764121
references: Nat Rev Drug Discov. 2010 May;9(5):373-86
references: 20431569
references: J Pharmacol Exp Ther. 2011 Aug;338(2):658-70
references: 21576380
references: Mol Pharmacol. 2010 Oct;78(4):756-66
references: 20647394
references: J Pharmacol Exp Ther. 2009 Jan;328(1):331-42
references: 18824613
references: J Neurochem. 1998 Apr;70(4):1567-76
references: 9523574
references: Biochem Pharmacol. 2011 May 15;81(10):1248-54
references: 21396918
references: Purinergic Signal. 2013 Mar;9(1):91-100
references: 23054444
references: J Pharmacol Exp Ther. 2005 Sep;314(3):1195-201
references: 15917400
references: Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62
references: 6141562
references: Psychopharmacology (Berl). 2009 Dec;207(3):413-22
references: 19816677
references: Br J Pharmacol. 2012 Nov;167(6):1259-70
references: 22725608
references: Mol Pharmacol. 2011 Sep;80(3):367-77
references: 21610196
references: Mol Pharmacol. 2012 Aug;82(2):178-88
references: 22553358
references: Neuropsychopharmacology. 2012 Jul;37(8):1953-62
references: 22491351
references: J Pharmacol Exp Ther. 2010 Mar;332(3):1127-35
references: 20008489
references: Pharmacol Rev. 2010 Jun;62(2):305-30
references: 20427692
references: J Auton Pharmacol. 1982 Dec;2(4):277-95
references: 7161296
references: BMJ. 2012 May 23;344:e2806
references: 22623631
references: Science. 2013 May 3;340(6132):615-9
references: 23519215
references: Biochem Pharmacol. 1999 Sep 1;58(5):735-48
references: 10449182
references: J Pharmacol Exp Ther. 2013 Mar;344(3):708-17
references: 23300227
references: J Pharmacol Exp Ther. 2007 Jan;320(1):1-13
references: 16803859
references: Pharmacol Biochem Behav. 2012 Mar;101(1):155-65
references: 22108651
references: Br J Pharmacol. 2011 Oct;164(4):1322-34
references: 21434879
references: J Neurosci. 2007 May 9;27(19):5092-104
references: 17494695
references: Sci Signal. 2011 Aug 9;4(185):ra52
references: 21868358
references: Nature. 1997 Apr 3;386(6624):499-502
references: 9087409
references: Proc Natl Acad Sci U S A. 1984 Nov;81(22):7253-7
references: 6095280
references: Mol Pharmacol. 2013 Mar;83(3):633-9
references: 23239825
references: Mol Pharmacol. 2008 Jan;73(1):178-90
references: 17947509
references: Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):549-77
references: 18253722
references: J Pharmacol Exp Ther. 2007 Jun;321(3):1193-207
references: 17392404
references: Br J Cancer. 2001 Mar 2;84(5):587-93
references: 11237376
references: Pain Physician. 2008 Mar;11(2 Suppl):S133-53
references: 18443637
references: Nature. 1956 Sep 29;178(4535):697-8
references: 13369505
references: PLoS One. 2012;7(8):e41909
references: 22912681
references: Mol Pharmacol. 1985 Nov;28(5):410-21
references: 4058422
references: Pediatrics. 2012 Dec;130(6):e1700-3
references: 23129079
references: Drug Alcohol Depend. 2012 Mar 1;121(3):173-80
references: 22129844
references: Mol Pharmacol. 1987 Nov;32(5):633-8
references: 2824980
references: J Pharmacol Exp Ther. 2012 Mar;340(3):567-76
references: 22129596
references: Trends Pharmacol Sci. 1998 Jul;19(7):270-6
references: 9703760
references: J Neurosci. 2011 May 11;31(19):7122-30
references: 21562274
references: J Biol Chem. 1997 Sep 19;272(38):23871-9
references: 9295336
references: Jpn J Pharmacol. 1981 Dec;31(6):905-9
references: 6278185
references: Expert Opin Drug Discov. 2011 Aug;6(8):811-25
references: 22651124
references: Mol Pharmacol. 1984 Nov;26(3):489-97
references: 6092898
references: J Neurosci. 2011 Apr 13;31(15):5617-24
references: 21490202
references: Mol Pharmacol. 2007 May;71(5):1416-26
references: 17322005
references: J Pharmacol Exp Ther. 1991 Aug;258(2):544-50
references: 1650833